15 employees
NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases
2014
$3.7M
from 3 investors over 3 rounds
NEUWAY Pharma GmbH raised $3.5M on October 29, 2015
Investors: Wellington Partners and KfW
NEUWAY Pharma GmbH raised $3.7M on May 27, 2014
Investors: Wellington Partners